Narrative Review: Gut Microbiota and Its Impact on α‐syn Function in Parkinson's Disease
MicrobiologyOpen · 2025-12 · 14 (6)
DOI: 10.1002/mbo3.70173 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MicrobiologyOpen, online erschienen am 05.12.2025. Verfasst von I Daniel Salinas-Velarde und 8 weiteren Autor:innen. Beteiligte Einrichtung: Facultad de Medicina, Universidad Autónoma del Estado de México, Estado de México, México. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Parkinson Disease, alpha-Synuclein. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCCIH NIH HHS, This review was funded by the "Consorcios Proyectos de Colaboración Interinstitucional UAM-IPN -UAEMEX" (grant number 7152/2024ECON) and publication grant 3450….
Abstract (Originalsprache)
Gut microbiota (GM) plays a pivotal role in human health and disease, and its alterations have been implicated in various neurological disorders, including Parkinson's disease (PD). Growing evidence reveals correlations between the abundance of specific bacterial taxa and the severity of motor symptoms and intestinal dysfunction in PD. Moreover, bacterial metabolites have been shown to influence α‐synuclein (α‐syn) aggregation and neurodegeneration. This narrative review aims to explore the current understanding of the gut‐brain axis in PD, specifically the connection between GM and α‐syn function in PD experimental models and patients. Several therapeutic strategies aimed at modulating gut microbiota, such as dietary interventions, fecal microbiota transplantation, and targeted bacterial therapies with the goal of alleviating or preventing PD symptoms, are examined. Understanding the mechanisms through which GM influence neurodegeneration, including inflammation, immune modulation, and microbial metabolite production, offers promising avenues for the development of novel therapeutic strategies targeting the microbiome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Facultad de Medicina, Universidad Autónoma del Estado de México, Estado de México, México.
- Departamento de Ciencias Ambientales, Universidad Autónoma Metropolitana-Lerma, Estado de México, México.
- Centro de Nanociencias y Micro y Nanotecnologías, Instituto Politécnico Nacional, CDMX, México.
- Escuela Superior de Medicina, Instituto Politécnico Nacional, Sección de Estudios de Posgrado e Investigación, CDMX, México.
- Departamento de Atención a la Salud, Universidad Autónoma Metropolitana-Xochimilco, CDMX, México.
ORCID-Profile: I Daniel Salinas-Velarde, José Félix Aguirre-Garrido, Rina María González-Cervantes
Förderung
- NCCIH NIH HHS
- This review was funded by the "Consorcios Proyectos de Colaboración Interinstitucional UAM-IPN -UAEMEX" (grant number 7152/2024ECON) and publication grant 3450…
Zitieren
APA
Salinas-Velarde, I. D., Donaciano-Domínguez, J. M., Oros-Pantoja, R., Aguirre-Garrido, J. F., González-Cervantes, R. M., Munguía-Cervantes, J. E., López, M. G., Bustos-Martínez, J., & Soto-Piña, A. E. (2025). Narrative Review: Gut Microbiota and Its Impact on α‐syn Function in Parkinson's Disease. MicrobiologyOpen, 14(6). https://doi.org/10.1002/mbo3.70173
Vancouver
Salinas-Velarde ID, Donaciano-Domínguez JM, Oros-Pantoja R, Aguirre-Garrido JF, González-Cervantes RM, Munguía-Cervantes JE, et al. Narrative Review: Gut Microbiota and Its Impact on α‐syn Function in Parkinson's Disease. MicrobiologyOpen. 2025;14(6). doi:10.1002/mbo3.70173
BibTeX
@article{SalinasVelarde2025,
author = {Salinas-Velarde, I Daniel and Donaciano-Domínguez, Juan Manuel and Oros-Pantoja, Rigoberto and Aguirre-Garrido, José Félix and González-Cervantes, Rina María and Munguía-Cervantes, Jacobo Esteban and López, Modesto Gómez and Bustos-Martínez, Jaime and Soto-Piña, Alexandra Estela},
title = {Narrative Review: Gut Microbiota and Its Impact on α‐syn Function in Parkinson's Disease},
journal = {MicrobiologyOpen},
year = {2025},
volume = {14},
number = {6},
doi = {10.1002/mbo3.70173}
}
EUVIMED